Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Volume reduction of blood or blood product (eg, red blood cells or platelets), each unit

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The procedure described by CPT® Code 86960 involves the reduction of the volume of blood or a specific blood product, such as red blood cells or platelets, prior to its infusion into a patient. This process is essential in managing various medical conditions where the volume of blood components needs to be adjusted to ensure optimal therapeutic outcomes. The reduction in volume can help minimize the risk of complications associated with transfusions, such as fluid overload, and can enhance the effectiveness of the transfusion by concentrating the necessary components. This procedure is particularly relevant in cases where patients may require transfusions but have limitations regarding the total volume of blood they can safely receive. By focusing on the volume reduction of blood products, healthcare providers can tailor transfusion therapies to meet individual patient needs while adhering to safety protocols.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 86960 is indicated for various clinical scenarios where the volume of blood or blood components needs to be reduced prior to transfusion. The following conditions may warrant this procedure:

  • Fluid Overload Risk Patients who are at risk of fluid overload, such as those with heart failure or renal impairment, may require volume reduction to prevent complications during transfusion.
  • Transfusion Reactions Individuals with a history of transfusion reactions may benefit from volume reduction to minimize the risk of adverse effects associated with larger volumes of blood products.
  • Specific Hematological Conditions Patients with certain hematological disorders may require concentrated blood components, necessitating volume reduction to enhance therapeutic efficacy.

2. Procedure

The procedure for volume reduction of blood or blood products involves several key steps to ensure that the transfusion is both safe and effective. Each step is critical to achieving the desired outcome while maintaining compliance with medical standards.

  • Step 1: Preparation of Blood Product The blood product, whether it be red blood cells or platelets, is first prepared in a sterile environment. This includes ensuring that the product is properly labeled and that all necessary documentation is in place to track the blood component throughout the process.
  • Step 2: Volume Reduction Process The actual volume reduction is performed using a centrifuge or other appropriate methods to separate the desired blood components from the excess volume. This step is crucial as it concentrates the necessary elements while discarding the superfluous volume, ensuring that the patient receives only what is needed.
  • Step 3: Quality Control After the volume reduction, the blood product undergoes quality control checks to confirm that it meets the required standards for transfusion. This includes verifying the concentration of red blood cells or platelets and ensuring that the product is free from contamination.
  • Step 4: Transfusion Preparation Once the volume reduction is complete and quality checks are passed, the blood product is prepared for transfusion. This involves ensuring that the product is at the appropriate temperature and that all transfusion equipment is sterile and ready for use.

3. Post-Procedure

Post-procedure care following the volume reduction of blood or blood products is essential to monitor the patient for any potential transfusion reactions or complications. Healthcare providers should observe the patient closely during the transfusion process, checking vital signs and watching for any signs of adverse reactions. Additionally, proper documentation of the procedure, including the volume reduced and the final product administered, is necessary for compliance and future reference. Patients may also require follow-up assessments to evaluate the effectiveness of the transfusion and to ensure that their condition is stable following the procedure.

Short Descr VOL REDUCTION OF BLOOD/PROD
Medium Descr VOLUME REDUCTION BLOOD/BLOOD PRODUCT EACH UNIT
Long Descr Volume reduction of blood or blood product (eg, red blood cells or platelets), each unit
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator STV-Packaged Codes
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
Date
Action
Notes
2006-01-01 Added First appearance in code book in 2006.
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"